Atlas Trials

Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT

Clinical trial NCT06757517 · RECRUITING

Trial details

NCT number
NCT06757517
Sponsor
St. Olavs Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Benzodiazepine Dependence
Start date
2022-03-01
Primary completion
2025-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.